Atlas Trials

Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.

Clinical trial NCT02107092 · COMPLETED

Trial details

NCT number
NCT02107092
Sponsor
ZS Pharma, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hyperkalemia
Start date
2014-05-31
Primary completion
2015-07-31
Enrollment
123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.